Baidu
map

Mol Cancer Res:YAP1蛋白触发脑膜瘤细胞增殖

2012-06-17 Beyond 生物谷

近日,约翰霍普金斯大学的研究人员发表论文称:他们已经发现脑膜瘤生长的重要的细胞机制之一。 在脑膜瘤细胞中,Baia研究激活的蛋白质YAP1,这是由Hippo调控的蛋白。没有Hippo,YAP1会移动到细胞核,并激活触发肿瘤细胞增殖的基因。 近年来,已发现Hippo信号通路在其他类型的癌细胞生长中发挥了作用,但该研究是第一次证实该通路与脑膜瘤有关。YAP1也与其他癌症有关联包括肺癌和卵巢的恶性肿

近日,约翰霍普金斯大学的研究人员发表论文称:他们已经发现脑膜瘤生长的重要的细胞机制之一。

在脑膜瘤细胞中,Baia研究激活的蛋白质YAP1,这是由Hippo调控的蛋白。没有Hippo,YAP1会移动到细胞核,并激活触发肿瘤细胞增殖的基因。

近年来,已发现Hippo信号通路在其他类型的癌细胞生长中发挥了作用,但该研究是第一次证实该通路与脑膜瘤有关。YAP1也与其他癌症有关联包括肺癌和卵巢的恶性肿瘤,NF2突变存在于其他不太常见的脑癌类型中。

在他们的研究中,研究人员收集了70例脑膜瘤组织样本,发现所有样品的原子核中都表达YAP1,并且不与肿瘤的发展历程相关,这意味着它似乎在脑膜瘤的早期阶段就存在。在实验室研究中,研究人员敲除细胞核YAP1后发现,肿瘤细胞增会受到抑制。但当YAP1表达增多时,细胞生长和迁移也更快。

研究人员正在开发针对这一靶基因的新的治疗方法。这项研究由Leonard和Phyllis Attman基金会捐款支持。(生物谷:Bioon.com)

doi:10.1158/1541-7786.MCR-12-0116
PMC:
PMID:

Yes-Associated Protein 1 Is Activated and Functions as an Oncogene in Meningiomas

G. S. Baia, O. L. Caballero, B. A. Orr, A. Lal, J. S. Y. Ho, C. Cowdrey, T. Tihan, C. Mawrin, G. J. Riggins.

The Hippo signaling pathway is functionally conserved in Drosophila melanogaster and mammals and its proposed function is to control tissue homeostasis by regulating cell proliferation and apoptosis. The core components are comprised of a kinase cascade that culminates with the phosphorylation and inhibition of Yes-associated protein 1 (YAP1). Phospho-YAP1 is retained in the cytoplasm. In the absence of Hippo signaling, YAP1 translocates to the nucleus, associates with co-activators TEAD1-4 and functions as a transcriptional factor promoting the expression of key target genes. Components of the Hippo pathway are mutated in human cancers and deregulation of this pathway plays a role in tumorigenesis. Loss of the NF2 tumor suppressor gene is the most common genetic alteration in meningiomas and the NF2 gene product, Merlin acts upstream of the Hippo pathway. Here we show that primary meningioma tumors have high nuclear expression of YAP1. In meningioma cells, Merlin expression is associated with phosphorylation of YAP1. Using a siRNA transient knockdown of YAP1 in NF2 mutant meningioma cells we show that suppression of YAP1 impaired cell proliferation and migration. Conversely, YAP1 overexpression led to a strong augment of cell proliferation and anchorage-independent growth, and restriction of cisplatin-induced apoptosis. In addition, expression of YAP1 in nontransformed arachnoidal cells led to the development of tumors in nude mice. Together, these findings suggest that in meningiomas deregulation of the Hippo pathway is largely observed in primary tumors and that YAP1 functions as an oncogene promoting meningioma tumorigenesis.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1715753, encodeId=e9fb1e1575317, content=<a href='/topic/show?id=24051893e0f' target=_blank style='color:#2F92EE;'>#YAP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18937, encryptionId=24051893e0f, topicName=YAP1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=941632034462, createdName=xinmeili, createdTime=Thu Oct 18 10:03:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081875, encodeId=781a20818e5e1, content=<a href='/topic/show?id=c2971893397' target=_blank style='color:#2F92EE;'>#YAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18933, encryptionId=c2971893397, topicName=YAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3333505, createdName=gujh, createdTime=Sun Feb 10 19:03:00 CST 2013, time=2013-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280818, encodeId=d7301280818c2, content=<a href='/topic/show?id=a55385062c7' target=_blank style='color:#2F92EE;'>#脑膜瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85062, encryptionId=a55385062c7, topicName=脑膜瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Tue Jun 19 11:03:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540859, encodeId=11a3154085960, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Tue Jun 19 11:03:00 CST 2012, time=2012-06-19, status=1, ipAttribution=)]
    2012-10-18 xinmeili
  2. [GetPortalCommentsPageByObjectIdResponse(id=1715753, encodeId=e9fb1e1575317, content=<a href='/topic/show?id=24051893e0f' target=_blank style='color:#2F92EE;'>#YAP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18937, encryptionId=24051893e0f, topicName=YAP1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=941632034462, createdName=xinmeili, createdTime=Thu Oct 18 10:03:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081875, encodeId=781a20818e5e1, content=<a href='/topic/show?id=c2971893397' target=_blank style='color:#2F92EE;'>#YAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18933, encryptionId=c2971893397, topicName=YAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3333505, createdName=gujh, createdTime=Sun Feb 10 19:03:00 CST 2013, time=2013-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280818, encodeId=d7301280818c2, content=<a href='/topic/show?id=a55385062c7' target=_blank style='color:#2F92EE;'>#脑膜瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85062, encryptionId=a55385062c7, topicName=脑膜瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Tue Jun 19 11:03:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540859, encodeId=11a3154085960, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Tue Jun 19 11:03:00 CST 2012, time=2012-06-19, status=1, ipAttribution=)]
    2013-02-10 gujh
  3. [GetPortalCommentsPageByObjectIdResponse(id=1715753, encodeId=e9fb1e1575317, content=<a href='/topic/show?id=24051893e0f' target=_blank style='color:#2F92EE;'>#YAP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18937, encryptionId=24051893e0f, topicName=YAP1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=941632034462, createdName=xinmeili, createdTime=Thu Oct 18 10:03:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081875, encodeId=781a20818e5e1, content=<a href='/topic/show?id=c2971893397' target=_blank style='color:#2F92EE;'>#YAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18933, encryptionId=c2971893397, topicName=YAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3333505, createdName=gujh, createdTime=Sun Feb 10 19:03:00 CST 2013, time=2013-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280818, encodeId=d7301280818c2, content=<a href='/topic/show?id=a55385062c7' target=_blank style='color:#2F92EE;'>#脑膜瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85062, encryptionId=a55385062c7, topicName=脑膜瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Tue Jun 19 11:03:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540859, encodeId=11a3154085960, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Tue Jun 19 11:03:00 CST 2012, time=2012-06-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1715753, encodeId=e9fb1e1575317, content=<a href='/topic/show?id=24051893e0f' target=_blank style='color:#2F92EE;'>#YAP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18937, encryptionId=24051893e0f, topicName=YAP1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=941632034462, createdName=xinmeili, createdTime=Thu Oct 18 10:03:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081875, encodeId=781a20818e5e1, content=<a href='/topic/show?id=c2971893397' target=_blank style='color:#2F92EE;'>#YAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18933, encryptionId=c2971893397, topicName=YAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3333505, createdName=gujh, createdTime=Sun Feb 10 19:03:00 CST 2013, time=2013-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280818, encodeId=d7301280818c2, content=<a href='/topic/show?id=a55385062c7' target=_blank style='color:#2F92EE;'>#脑膜瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85062, encryptionId=a55385062c7, topicName=脑膜瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Tue Jun 19 11:03:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540859, encodeId=11a3154085960, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Tue Jun 19 11:03:00 CST 2012, time=2012-06-19, status=1, ipAttribution=)]

相关资讯

PNAS:癌症起源的新线索

不同类型肿瘤的产生依赖于DNA损伤效应、细胞周期关键点以及凋亡的特定蛋白质的突变。(Credit: Image courtesy of Institute for Research in Biomedicine-IRB) 近日,来自巴塞罗那生物医药研究所(IRBB)和斯隆凯特琳癌症研究中心(MSKCC)的研究者揭示了癌症起源新的研究信息,这项研究刊登在了国际著名杂志PNAS上。文章中,研究者表示

Cancer Res:纤蛋白-3激活Notch通路促进神经胶质细胞瘤恶性

6月4日Cancer Research杂志在线报道了纤蛋白-3促进肿瘤侵袭的机制研究新发现。纤蛋白-3是一种不存在于正常大脑,而在神经胶质细胞瘤中显著上调的基质蛋白。其促进肿瘤侵袭的机制不明。恶性神经胶质细胞瘤是高侵袭性、化疗抵抗性脑瘤,预后极差。浸润性神经胶质细胞瘤细胞是复发的主要来源。针对触发侵袭和化疗抵抗的可溶性因子,也许可以对这类癌细胞有显著的抑制效果。 这项研究揭示:纤蛋白-3作为No

Neoplasia:陈吉龙等免疫细胞癌变的信号通路研究中获新进展

免疫细胞癌变可导致各种白血病/淋巴癌的发生,这些是人类常见的恶性肿瘤。淋巴细胞和粒细胞等由于某些特殊原因发生变异而诱发细胞癌变,其中Bcr-Abl融合癌基因主要诱发了慢性粒细胞白血病(CML)和急性淋巴细胞白血病(ALL)。Bcr-Abl癌蛋白介导细胞癌变的过程涉及多种信号转导通路的分子调控,其中JAK/STAT是关键信号通路之一。SOCS家族蛋白作为细胞因子信号通路的抑制因子,能有效地调节JAK

Cancer Res.:肿瘤缺氧途径研究新模型

6月4日Cancer Research杂志在线报道了一种新开发的缺氧感受信号通路斑马鱼体内研究系统,为深入研究缺氧在肿瘤中作用提供了有力的新手段。 缺氧信号通路是肿瘤细胞病理过程的核心调控者。过去对氧浓度感受途径的关键因子von Hippel-Lindau肿瘤抑制蛋白(pVHL)以及HIF转录因子虽然研究得很多,但是还需要加强在生物模型中对缺氧途径的研究,以加深人类对肿瘤病理的理解,促进新治疗手

Blood:药物组合疗法有助治疗多发性骨髓瘤

三种药物治疗为一种血癌类型--多发性骨髓瘤提供了快速,深刻的和潜在的持久的反应,研究人员将最新研究论文发表在Blood杂志上。 芝加哥大学医学中心的主任医师Andrzej J. Jakubowiak博士带领研究人员发现相比原于一线治疗方案,carfilzomib(新一代蛋白酶抑制剂)联合lenalidomide和低剂量地塞米松治疗多发性骨髓瘤效果更好。 Jakubowiak说:这些迅速和持久的

Nat Struct Mol Biol:内含子RNA调节EZH2表观遗传调控

6月3日,Nature Structural & Molecular Biology杂志报道了内含子RNA调节组蛋白赖氨酸N端甲基转移酶EZH2表观遗传调控的最新进展。 在基因组许多位点的表观遗传修饰异常是肿瘤的一个重要特征。有观点认为,某些RNA分子可指导抑制性多梳蛋白复合物(PRC2)到达特定的染色质区域。 研究者利用体内交叉连接手段在肿瘤细胞中检测和确定PRC2-RNA直接相互作

Baidu
map
Baidu
map
Baidu
map